2019 Annual Meeting | C217 - Core Concepts in Pain Management: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids
Date
Thursday 05/09/19
Time
01:00 PM - 03:00 PM EDT
Add To Calendar
Session Format
This program will be presented both in-person and online
On Demand
This program is not expected to be available in the meeting's On Demand product.
Event Type
Seminar
Director(s)
James C. Watson, MD
Topic(s)
Pain
Learning Objectives
Participants should be able to discuss strategies to mitigate the failure of first line neuropathic pain adjuvants, understand second line pharmacologic and topical treatments, and the role of opioids in neuropathic pain treatment. Participants will understand the expanding types and targets of neuromodulation and where they fit in the treatment algorithm. Participants will understand the facts and fiction behind the use of cannabinoids in the treatment of neuropathic pain.
CME Available
2.00 CME credits
Core Competencies
Patient Care & Procedural Skills
Program Level
Intermediate
Recommended Audience
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Teaching Styles
Case-based, Didactic, Audience Participation
Program Materials
Program Evaluations
Event Timeline
01:00 PM - 01:05 PM EDT
Introduction
Introduction
01:05 PM - 01:40 PM EDT
Speaker
Neuropathic Pain: Symptomatic Management and Mitigating First Line Pharmacologic Failures
01:40 PM - 02:15 PM EDT
Speaker
Neuromodulation: Evolving Technologies, Targets, and Uses
02:15 PM - 02:50 PM EDT
Speaker
Cannabinoids: Fact or Fiction – A Balanced Look at Cannabinoid Usage for Neuropathic Pain
02:50 PM - 03:00 PM EDT
Q&A
Questions and Answers
Faculty Disclosures
James C. Watson, MD
No disclosure on file
Jason Eldrige, MD
No disclosure on file
Thomas Pittelkow, DO, MPH
No disclosure on file